UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010518 |
|---|---|
| Receipt number | R000012300 |
| Scientific Title | Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment |
| Date of disclosure of the study information | 2013/04/19 |
| Last modified on | 2020/10/29 13:33:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment
Acronym
Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment
Scientific Title
Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment
Scientific Title:Acronym
Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment
Region
| Japan |
Condition
Condition
type 2 diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To compare insulin glarugine and insulin degludec for efficancy in basal-bolus treatment in type 2 diabetes
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Comparison of glucose variability between two treatments by the Continuous Glucose Monitoring System (Frequency of nocturnal hypoglycemia by basal-bolus insulin treatment with glarugine and degludec)
Key secondary outcomes
1)Standard deviation of nocturnal blood glucose levels
2)Correlation between ability of insulin secretion and Bolus/ Basal insulin ratio
3)Correlation between ability of insulin secretion and the frequency of nocturnal hypoglycemia
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Hospitalized patients with type 2 diabetes under Basal-Bolus insulin therapy with glargine will be enrolled. First CGMS for 72-h will be performed after fasting blood glucose are controlled to the range from 80mg/dl to 130mg/dl (First basal period). Then, Insulin glargine will be replaced to same dose decrutec without changing bolus insulin,and second CGMS will be performed.
Interventions/Control_2
Hospitalized patients with type 2 diabetes under Basal-Bolus insulin therapy with degludec will be enrolled. First CGMS for 72-h will be performed after fasting blood glucose are controlled to the range from 80mg/dl to 130mg/dl (First basal period). Then, Insulin decrutec will be replaced to same dose glargine without changing bolus insulin,and second CGMS will be performed.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 75 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Patients with type 2 diabetes who meet the following conditions:
(1)Age: younger than 75 years old, elder than 20 years old
(2)recent HbA1c : less than 12.0%
Key exclusion criteria
Patients who falls under any of the following conditions shall be excluded:
(1)diabetic coma
(2)severe renal dysfunction (eGFR less than 30)
(3)unstable pre or proliferative diabetic retinopathy
(4)severe infection
(5)administered steroid drugs
(6)pregnant or planned pregnant in the near future
(7)ineligible for some other medical reasons judged by the investigator
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Akira |
| Middle name | |
| Last name | Kawashima |
Organization
Naga Municipal Hospital
Division name
Department of Internal Medicine
Zip code
649-6414
Address
1282 Uchita, Kinokawa City, Wakayama 649-6414, Japan
TEL
0736772019
soumu@nagahp.jp
Public contact
Name of contact person
| 1st name | Tetsushi |
| Middle name | |
| Last name | Nasu |
Organization
Naga Municipal Hospital
Division name
Department of Internal Medicine
Zip code
649-6414
Address
1282 Uchita, Kinokawa City, Wakayama 649-6414, Japan
TEL
0736772019
Homepage URL
soumu@nagahp.jp
Sponsor or person
Institute
Naga Municipal Hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Naga Municipal Hospital
Address
1282 Uchita, Kinokawa City, Wakayama 649-6414, Japan
Tel
0736772019
soumu@nagahp.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
公立那賀病院内科 Department of Internal Medicine, Naga Municipal Hospital
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 04 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2013 | Year | 04 | Month | 15 | Day |
Date of IRB
| 2013 | Year | 04 | Month | 16 | Day |
Anticipated trial start date
| 2013 | Year | 04 | Month | 19 | Day |
Last follow-up date
| 2013 | Year | 07 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 04 | Month | 17 | Day |
Last modified on
| 2020 | Year | 10 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012300
